Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZYNE | GBIO | ASMB | ||
| Company | Zynerba Pharma CS | Generation Bio Co. | Assembly Biosciences | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2600 | 3.06 | 13.40 | ||
| High | 1.3400 | 3.11 | 13.43 | ||
| Low | 1.2600 | 2.85 | 12.00 | ||
| Last | 1.3000 | 2.90 | 12.65 | ||
| Change | +0.0300 | -0.11 | -0.71 | ||
| % Change | +2.36% | -3.65% | -5.31% | ||
| Volume | 862,700 | 92,000 | 29,500 | ||
| 20-Day Average Volume | 1,093,995 | 219,930 | 18,620 | ||
| Previous Close | 1.2700 | 3.01 | 13.36 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3012 | 3.53 | 13.82 | ||
| 20-Day Raw Stochastic | 53.49% | 10.26% | 20.38% | ||
| 20-Day Relative Strength | 62.80% | 45.96% | 45.78% | ||
| Weighted Alpha | -35.90 | +8.44 | -4.61 | ||
| Today's Opinion | 80% Buy | 24% Buy | 56% Buy | ||
| Previous Opinion | 80% Buy | 40% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.17% since 10/03/23 | +3.57% since 04/19/24 | -5.67% since 04/19/24 | ||
| Low | 1.1850 on 10/04/23 | 2.75 on 04/22/24 | 12.00 on 04/26/24 | ||
| High | 1.3400 on 10/10/23 | 3.40 on 04/23/24 | 13.66 on 04/22/24 | ||
| 1-Month | |||||
| %Chg | -1.52% since 09/08/23 | -8.52% since 03/26/24 | -3.14% since 03/26/24 | ||
| Low | 1.1850 on 10/04/23 | 2.70 on 04/19/24 | 12.00 on 04/26/24 | ||
| High | 1.4000 on 09/15/23 | 4.65 on 04/01/24 | 15.19 on 04/15/24 | ||
| 3-Month | |||||
| %Chg | +293.70% since 07/10/23 | +62.92% since 01/26/24 | +17.12% since 01/26/24 | ||
| Low | 0.2500 on 07/11/23 | 1.75 on 01/29/24 | 9.84 on 02/08/24 | ||
| High | 1.4000 on 09/15/23 | 4.65 on 04/01/24 | 15.19 on 04/15/24 | ||
| 6-Month | |||||
| %Chg | +225.00% since 04/10/23 | +202.68% since 10/26/23 | +29.47% since 10/26/23 | ||
| Low | 0.2500 on 07/11/23 | 0.89 on 10/27/23 | 7.69 on 11/22/23 | ||
| High | 1.4000 on 09/15/23 | 4.65 on 04/01/24 | 15.19 on 04/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 70,121 | 192,818 | 69,357 | ||
| Shares Outstanding, K | 53,939 | 66,489 | 5,483 | ||
| Annual Sales | 0 | 5,900,000 | 7,160,000 | ||
| Annual Net Income | -35,040,000 | -126,610,000 | -61,230,000 | ||
| Last Quarter Sales | 0 | 2,880,000 | 7,160,000 | ||
| Last Quarter Net Income | -10,780,000 | -35,190,000 | -10,960,000 | ||
| 60-Month Beta | 1.32 | 2.79 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/14/23 | -0.53 on 03/06/24 | -3.24 on 11/08/23 | ||
| Latest Earnings Date | 11/13/23 | 05/08/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||